News & Events – HCP Papilloguard

PapilloGuard® Knowledge Hub
This section provides access to scientific articles, expert insights, and educational resources focused on PapilloGuard®, the quadrivalent HPV vaccine. Created in collaboration with leading specialists and academic institutions, this platform delivers continuously updated clinical data, vaccination strategies, and expert commentary to support healthcare professionals in evidence-based decision-making and best practices in HPV prevention.

Prevention and control of HPV-related cancers in people living with HIV

Authors: Anneli Uusküla, Anna Tisler, Jack DeHovitz, Gad Murenzi, Philip E Castle, Gary Clifford
Journal: The Lancet Journal

August 3, 2025

Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination

Authors: Talía Malagón, Eduardo L. Franco, Romina Tejada & Salvatore Vaccarella
Journal: Nature Reviews Clinical Oncology

August 3, 2025

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

Authors: Milena Falcaro, Alejandra Castañon, Busani Ndlela, Marta Checchi, Kate Soldan, Jamie Lopez-Bernal, Lucy Elliss-Brookes, Peter Sasieni
Journal: The Lancet Journal

June 10, 2025

This website is for healthcare professionals in Iran. PapilloGuard® is a prescription medicine by Nivad Pharmed and Orchid Pharmed. Related trademarks, including the injection device and Orchid Life® services, are owned or licensed by them.